Literature DB >> 8014490

Interaction of polymorphonuclear leukocytes with Yersinia enterocolitica: role of the Yersinia virulence plasmid and modulation by the iron-chelator desferrioxamine B.

J H Ewald1, J Heesemann, H Rüdiger, I B Autenrieth.   

Abstract

The impact of desferrioxamine B (DFOB) on intracellular calcium mobilization, chemoluminescence (CL) signaling, phagocytosis, and bacterial killing of Yersinia enterocolitica by polymorphonuclear leukocytes (PMNL) was investigated. DFOB did not alter calcium signaling in PMNL but transiently increased phagocytosis. Likewise, higher counts of viable bacteria in PMNL and increased CL signals after stimulation with Y. enterocolitica were observed in the presence of DFOB. However, DFOB reduced the CL signal elicited individually by zymosan, PMA, and FMLP. Comparison of plasmid-cured with plasmid-harboring Y. enterocolitica revealed that plasmid-encoded determinants modulate phagocytosis, CL signal, and bactericidal properties of PMNL. These data demonstrate that DFOB alters microbicidal properties of PMNL and modulates their interaction with Y. enterocolitica and provide further evidence for a putative dual role of DFOB in the pathogenesis of Yersinia infection, namely growth support of the pathogen and modulation of the antimicrobial host response.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8014490     DOI: 10.1093/infdis/170.1.140

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Deletion of amino acids 29 to 81 in adhesion protein YadA of Yersinia enterocolitica serotype O:8 results in selective abrogation of adherence to neutrophils.

Authors:  A Roggenkamp; K Ruckdeschel; L Leitritz; R Schmitt; J Heesemann
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Common and specific characteristics of the high-pathogenicity island of Yersinia enterocolitica.

Authors:  A Rakin; C Noelting; S Schubert; J Heesemann
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

3.  Conjugation of hydroxyethyl starch to desferrioxamine (DFO) modulates the dual role of DFO in Yersinia enterocolitica infection.

Authors:  S Schubert; I B Autenrieth
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

4.  Translocation of Yersinia enterocolitica through an endothelial monolayer by polymorphonuclear leukocytes.

Authors:  H Rüssmann; K Ruckdeschel; J Heesemann
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

5.  Differential contribution of Yersinia enterocolitica virulence factors to evasion of microbicidal action of neutrophils.

Authors:  K Ruckdeschel; A Roggenkamp; S Schubert; J Heesemann
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

Review 6.  The virulence plasmid of Yersinia, an antihost genome.

Authors:  G R Cornelis; A Boland; A P Boyd; C Geuijen; M Iriarte; C Neyt; M P Sory; I Stainier
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

Review 7.  Pathogenicity islands in bacterial pathogenesis.

Authors:  Herbert Schmidt; Michael Hensel
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

8.  Bactericidal properties of Campylobacter jejuni-specific immunoglobulin M antibodies in commercial immunoglobulin preparations.

Authors:  I B Autenrieth; A Schwarzkopf; J H Ewald; H Karch; R Lissner
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

9.  Yersiniabactin reduces the respiratory oxidative stress response of innate immune cells.

Authors:  Armand Paauw; Maurine A Leverstein-van Hall; Kok P M van Kessel; Jan Verhoef; Ad C Fluit
Journal:  PLoS One       Date:  2009-12-29       Impact factor: 3.240

10.  Yersinia enterocolitica targets cells of the innate and adaptive immune system by injection of Yops in a mouse infection model.

Authors:  Martin Köberle; Annegret Klein-Günther; Monika Schütz; Michaela Fritz; Susanne Berchtold; Eva Tolosa; Ingo B Autenrieth; Erwin Bohn
Journal:  PLoS Pathog       Date:  2009-08-14       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.